Header Logo

Connection

Donald Kastens to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications Donald Kastens has written about Adenocarcinoma.
Donald Kastens
Connection Strength
0.035
Adenocarcinoma
  1. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus. Cancer. 1999 Sep 01; 86(5):756-63.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.